Sterling Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Sterling Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,592	Closed	-$15.3K	–	3250
2024 Q4	$15.3K	Buy	1,592 +1,416	+805%	+$7.39K	﹤0.01%	1969
2024 Q3	$503	Buy	+176	New	+$545	﹤0.01%	2867

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's PSTX Position: Q1 2025 in Review

Sterling Capital Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 1,592 shares — an estimated $15.3K sold.

Sterling Capital Management first reported a position in PSTX in Q3 2024 and held it in 2 quarters. The position peaked at $15.3K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Sterling Capital Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Sterling Capital Management sold 1,592 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $15.3K.
Sterling Capital Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
Sterling Capital Management's Poseida Therapeutics, Inc. Common Stock position peaked at $15.3K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Sterling Capital Management's 13F filing for Q1 2025, filed 13 May 2025.